Skip to content

Smoking Cessation Intervention in Acute Orthopedic Surgery

Smoking Cessation Intervention in Acute Orthopedic Surgery - A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00704015
Enrollment
105
Registered
2008-06-24
Start date
2004-02-29
Completion date
2008-06-30
Last updated
2008-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture, Smoking Cessation

Keywords

Smoking cessation, Acute injury, Musculoskeletal, Postoperative complications

Brief summary

The purpose of this study was to evaluate if an intervention with smoking cessation starting during the acute hospitalization period and continuing during the acute postoperative phase of 6 weeks would reduce the frequency of overall postoperative complications and wound infections in patients with acute musculoskeletal injuries requiring surgical treatment. The secondary aims were to study the short and the long term (1 year) abstinence rate, functional outcome, health related quality of life as well as costs.

Detailed description

Tobacco smoking is a major health problem. The effect of a smoking cessation intervention prior to elective orthopedic surgery has been evaluated previously. However, as far as we know there are no prospective randomized studies investigating the effect of smoking cessation on complication rate in patients with acute musculoskeletal injuries.

Interventions

BEHAVIORALSmoking cessation

Nurses, specifically trained for smoking cession program, contacted the patients at the orthopedic wards and initiated the intervention (stop smoking) within 1-2 days after acute hospitalization. The intervention included one or two personal meetings and weekly phone contacts during 6 weeks with a trained nurse. A phone number to a non-smoking hotline was provided for all patients. The patients were continuously encouraged not to smoke and free nicotine substitution (Nicorette®) was offered those who needed it. No other drug therapy was used.

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* daily smoker: more than 2 cigarettes per day for at least one year * acute fracture of an extremity, in need of surgical treatment * oral and written consent

Exclusion criteria

* pregnancy * alcohol or drug abuse prohibiting compliance with the study protocol * living outside the county of Stockholm prohibiting follow-up * a severe mental illness including dementia * inability to read and understand Swedish

Design outcomes

Primary

MeasureTime frame
Postoperative complications including wound related complications6-12 weeks

Secondary

MeasureTime frame
Abstinence rate and functional outcome including HRQoL1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026